CBD and migraine: leads, limits and what to avoid

The endocannabinoid system regulates many physiological functions, including the perception of pain, through the CB1 and CB2 receptors, according to the Inserm. This biological mechanism explains the scientific interest taken in cannabinoids in research on chronic pain in general, migraine included.

That interest nevertheless remains theoretical for as long as it is not confirmed by robust clinical trials conducted specifically on migraine. A biologically plausible mechanism does not, on its own, constitute proof of clinical effectiveness in a human migraine sufferer.

Migraine and tension headache are two distinct medical entities, with different mechanisms and different treatments. Confusing the two often leads to poorly calibrated expectations of CBD, whose possible effects, if they exist, would not necessarily be identical across these two types of pain.

This distinction matters all the more because most of the available studies on cannabinoids and pain do not deal specifically with migraine, but with broader chronic pain, which limits how directly the results can be transposed.

Clinical trials devoted to CBD alone against migraine remain rare and inconclusive, according to the 2023-2024 reviews. Some studies explore CBD-THC combinations or broader cannabis extracts, which makes it harder to isolate the effect specific to CBD in the results observed.

As knowledge currently stands, no firm conclusion can be drawn about the effectiveness of CBD against migraine. Our article on CBD and brain fog illustrates a similar approach to another subject where research remains limited.

In France, no CBD product may claim a therapeutic effect, as the MILDECA points out. This rule applies whatever the symptom targeted, migraine included, and protects consumers from commercial messaging that would run ahead of the real state of scientific knowledge.

A CBD product presented as a treatment for migraine would therefore be in breach of the French regulatory framework, regardless of the seller's sincerity. Our article on CBD for relieving pain looks more broadly at what the regulations do, and do not, allow anyone to state.

Avoid treating CBD as an alternative to a prescribed anti-migraine treatment, or delaying a medical consultation in the event of frequent or unusual attacks. Migraine can have multiple causes that deserve a medical diagnosis, not self-medication.

CBD does not replace medical advice, and anyone suffering from recurrent migraines has everything to gain from discussing it with a doctor, the only person able to assess the situation and direct them towards appropriate care.

Is CBD effective against migraine?

Clinical trials devoted to CBD alone against migraine remain rare and inconclusive, according to the 2023-2024 reviews. No firm scientific conclusion can therefore be asserted to date.

What is the difference between migraine and tension headache?

They are two distinct types of headache, with different mechanisms. Most research on cannabinoids and pain does not always distinguish precisely between these two categories.

Can an "anti-migraine" CBD product be bought in France?

Not lawfully. No CBD product may claim a therapeutic effect in France, as the MILDECA points out, whatever the symptom targeted by the commercial argument.

Can CBD replace my migraine treatment?

No. CBD is not a medicine and must never replace a prescribed treatment. Any question about managing migraines should be put to a healthcare professional.